Annual ROA
-404.68%
+464.13%+53.42%
31 December 2022
Summary:
Nymox Pharmaceutical annual return on assets is currently -404.68%, with the most recent change of +464.13% (+53.42%) on 31 December 2022. During the last 3 years, it has fallen by -165.91% (-69.49%).NYMX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-117.25%
+133.79%+53.29%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly return on assets is currently -117.25%, with the most recent change of +133.79% (+53.29%) on 31 March 2023.NYMX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | -69.5% | +56.0% |
5 y5 years | -73.0% | +26.0% |
NYMX ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | +469.1% | +202.9% |
Nymox Pharmaceutical ROA History
Date | Annual | Quarterly |
---|---|---|
Mar 2023 | - | -117.25%(-53.3%) |
Dec 2022 | -404.68%(-53.4%) | -251.04%(-19.7%) |
Sept 2022 | - | -312.63%(-12.7%) |
June 2022 | - | -358.13%(-22.2%) |
Mar 2022 | - | -460.05%(+30.4%) |
Dec 2021 | -868.81%(+263.9%) | -352.92%(+32.5%) |
Sept 2021 | - | -266.42%(-18.6%) |
June 2021 | - | -327.36%(-9.6%) |
Mar 2021 | - | -362.13%(+23.4%) |
Dec 2020 | -238.77%(+23.0%) | -293.48%(+9.4%) |
Sept 2020 | - | -268.16%(+34.8%) |
June 2020 | - | -199.00%(+16.1%) |
Mar 2020 | - | -171.47%(+10.3%) |
Dec 2019 | -194.06%(-17.1%) | -155.42%(-1.9%) |
Sept 2019 | - | -158.47%(-7.8%) |
June 2019 | - | -171.92%(-2.0%) |
Mar 2019 | - | -175.47%(-33.9%) |
Dec 2018 | -233.99%(-73.5%) | -265.46%(-35.2%) |
Sept 2018 | - | -409.42%(-35.6%) |
June 2018 | - | -635.38%(-35.3%) |
Mar 2018 | - | -981.34%(+15.0%) |
Dec 2017 | -884.65%(-6.6%) | -853.31%(+12.6%) |
Sept 2017 | - | -757.98%(-5.8%) |
June 2017 | - | -804.44%(-12.6%) |
Mar 2017 | - | -920.10%(-17.9%) |
Dec 2016 | -946.91%(-43.5%) | -1120.27%(-30.5%) |
Sept 2016 | - | -1611.94%(-37.8%) |
June 2016 | - | -2589.49%(+3.1%) |
Mar 2016 | - | -2510.89%(+38.3%) |
Dec 2015 | -1676.59%(+335.9%) | -1815.99%(+31.5%) |
Sept 2015 | - | -1381.09%(+194.7%) |
June 2015 | - | -468.62%(+976.3%) |
Mar 2015 | - | -43.54%(-90.5%) |
Dec 2014 | -384.61%(+6.6%) | -458.65%(-21.5%) |
Sept 2014 | - | -584.24%(+2.5%) |
June 2014 | - | -569.85%(+16.3%) |
Mar 2014 | - | -489.99%(+48.0%) |
Dec 2013 | -360.85%(+92.3%) | -331.05%(-11.3%) |
Sept 2013 | - | -373.09%(+15.4%) |
June 2013 | - | -323.31%(+18.6%) |
Mar 2013 | - | -272.57%(+19.4%) |
Dec 2012 | -187.65%(+93.2%) | -228.31%(+51.5%) |
Sept 2012 | - | -150.73%(+18.6%) |
June 2012 | - | -127.14%(+23.1%) |
Mar 2012 | - | -103.32%(-5.8%) |
Dec 2011 | -97.12%(+8.4%) | -109.71%(-16.0%) |
Sept 2011 | - | -130.60%(-15.1%) |
June 2011 | - | -153.83%(-17.2%) |
Mar 2011 | - | -185.76%(-1.1%) |
Dec 2010 | -89.58% | -187.78%(-66.5%) |
Sept 2010 | - | -560.95%(+9.5%) |
June 2010 | - | -512.40%(+8.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | -472.18%(-3.4%) |
Dec 2009 | -557.52%(+201.2%) | -488.86%(+81.9%) |
Sept 2009 | - | -268.76%(+33.3%) |
June 2009 | - | -201.65%(+33.6%) |
Mar 2009 | - | -150.96%(+17.3%) |
Dec 2008 | -185.11%(+44.0%) | -128.67%(+10.5%) |
Sept 2008 | - | -116.48%(+2.5%) |
June 2008 | - | -113.63%(-5.6%) |
Mar 2008 | - | -120.31%(-0.8%) |
Dec 2007 | -128.55%(+1.0%) | -121.28%(-1.1%) |
Sept 2007 | - | -122.59%(-0.0%) |
June 2007 | - | -122.60%(+0.4%) |
Mar 2007 | - | -122.15%(-1.6%) |
Dec 2006 | -127.28%(+38.2%) | -124.17%(+7.9%) |
Sept 2006 | - | -115.12%(+6.5%) |
June 2006 | - | -108.12%(+13.8%) |
Mar 2006 | - | -95.02%(+0.1%) |
Dec 2005 | -92.09%(-0.8%) | -94.91%(-1.9%) |
Sept 2005 | - | -96.74%(+9.0%) |
June 2005 | - | -88.75%(-7.0%) |
Mar 2005 | - | -95.41%(+1.5%) |
Dec 2004 | -92.84%(-10.9%) | -94.01%(-11.0%) |
Sept 2004 | - | -105.66%(-4.6%) |
June 2004 | - | -110.78%(+2.0%) |
Mar 2004 | - | -108.60%(+3.2%) |
Dec 2003 | -104.15%(+30.1%) | -105.24%(+14.9%) |
Sept 2003 | - | -91.57%(+0.9%) |
June 2003 | - | -90.78%(+13.4%) |
Mar 2003 | - | -80.08%(+0.8%) |
Dec 2002 | -80.04%(+12.6%) | -79.44%(-1.6%) |
Sept 2002 | - | -80.76%(+4.8%) |
June 2002 | - | -77.08%(+3.9%) |
Mar 2002 | - | -74.20%(+7.4%) |
Dec 2001 | -71.11%(-42.3%) | -69.11%(-3.2%) |
Sept 2001 | - | -71.37%(-9.3%) |
June 2001 | - | -78.67%(-8.9%) |
Mar 2001 | - | -86.36%(-15.7%) |
Dec 2000 | -123.34%(+14.0%) | -102.47%(-8.0%) |
Sept 2000 | - | -111.39%(-2.6%) |
June 2000 | - | -114.37%(+16.7%) |
Mar 2000 | - | -97.97%(-13.9%) |
Dec 1999 | -108.16%(-26.7%) | -113.83%(-2.1%) |
Sept 1999 | - | -116.33%(+6.7%) |
June 1999 | - | -109.04%(-6.8%) |
Mar 1999 | - | -116.98%(-8.4%) |
Dec 1998 | -147.50%(+5.4%) | -127.66%(+11.1%) |
Sept 1998 | - | -114.93%(+8.3%) |
June 1998 | - | -106.16%(-4.7%) |
Mar 1998 | - | -111.37%(+10.2%) |
Dec 1997 | -140.00% | -101.02%(+42.0%) |
Sept 1997 | - | -71.13%(+83.8%) |
June 1997 | - | -38.71% |
FAQ
- What is Nymox Pharmaceutical annual return on assets?
- What is the all time high annual ROA for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly return on assets?
- What is the all time high quarterly ROA for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual return on assets?
The current annual ROA of NYMX is -404.68%
What is the all time high annual ROA for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual return on assets is -71.11%
What is Nymox Pharmaceutical quarterly return on assets?
The current quarterly ROA of NYMX is -117.25%
What is the all time high quarterly ROA for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly return on assets is -38.71%